Jump to content

Search the Community

Showing results for tags 'Propecia'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Mens Hair Loss
    • Welcome
    • Hair Loss General Discussion
    • Hair Loss Treatments
    • Hair Loss News
    • Hair Transplants
    • Hair Transplant Repair Forum
    • Scalp Micro Pigmentation
    • Travel Section
    • Hair Pieces, Wigs and Systems
    • Hair Loss Concealers and Cover Ups
    • Natural Treatments
  • Women's Hair Loss
    • Women's Hair Loss General
    • Women's Hair Loss Treatments
  • Off Topic
    • Off Topic Subjects

Blogs

  • Hair Loss News Blog

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


AIM


MSN


Website URL


ICQ


Yahoo


Jabber


Skype


Location


Interests

Found 16 results

  1. A Propecia Peyronie’s disease lawsuit has been filed against Merck & Co, Inc. by a Madison County, AL husband and wife. The plaintiffs claim thatMerck either knew, or should have known, that hair loss drug Propecia can cause serious side effects when used as intended, including cognitive impairment, sexual dysfunction and depression. The plaintiffs seek compensatory and special damages form Merck, as well as punitive damages because Merck allegedly demonstrated reckless indifference to the health and well-being of the public. The lawsuit claims that the plaintiff suffered cognitive impairment, as well as severe sexual dysfunction and Peyronie’s disease after taking Propecia to treat male pattern hair loss. The plaintiffs allege that these side effects continued after the use of Propecia was discontinued and that both husband and wife are experiencing ongoing losses including diminished quality of life and a loss of their sexual relationship. Complete article
  2. The law firm of d’Oliveira & Associates is working with some of the leading Propecia lawyers in the country handling Propecia cases and want the public to know that they offer a “No Win No Fee Promise” for Propecia users who have allegedly developed either breast or prostate cancer or suffered a permanent sexual dysfunction as a result of propeica use. ABC News reported that the popular hair-loss drug, Propecia, has been linked to its increases in its users developing permanent sexual dysfunctions (i). ABC News referenced a study that was published in the Journal of Sexual Medicine and conducted by researchers at George Washington University that found Propecia's use poses a significant threat to incompetence in its users. According to the same article, Propecia’s side effects may persist for months or years after discontinuing use of the drug (ii). Marketed by Merck & Co., Inc., Propecia is a commonly used drug meant to stop hair loss in men that was approved by The U.S. Food and Drug Administration (FDA) in 1997. In the 15 years since its approval, Propecia has been the center of several international studies examining the drug's link to both sexual dysfunction and breast and prostate cancer. The FDA cited a study conducted by the Medical Therapy of Prostatic Symptoms, when it announced that it was not ready to rule out the possibility that Propecia increases a user's risk of developing breast or prostate cancer (iii). Also recently, Health Canada reached a similar conclusion when it received numerous reports of Propecia users developing male breast cancer (iv). In addition to Propecia's links to breast and prostate cancer, the drug has now been attacked for its links of causing long-term and permanent sexual dysfunction in its users. Similar to the claims of cancer risks, Propecia's links to permanent dysfunctions have been studied in numerous countries. In 2008, the Swedish Medical Products Agency investigated the risk and urged Swedish authorities to force Merck to include in its warnings the risk or "persistent erectile dysfunction (v)." Additionally, in the George Washington University study, researchers found that Propecia users, who showed no symptoms of dysfunction prior to the study, were are a significantly increased risk, and that for those men who suffered from the side effects, that 96% of them reported it lasting for over a year after stopping Propecia use (vi). To help protect the rights of individuals who may have suffered injuries sexual dysfunction or even breast or prostate cancer while using Propecia to treat hair loss, d'Oliveira & Associates is offering a No Win, No Fee Promise. Those who choose to hire d'Oliveira & Associates will be charged no fee unless they recover monetary damages, such as through a settlement or judgment. Complete article
  3. In one of the more recent Propecia lawsuits, a Massachusetts man filed a case against manufacturer Merck & Co., Inc. on January 8, 2012 alleging that he suffered from severe side effects as a result of taking the anti-baldness medication. He states that these side effects have damaged his quality of life and requests $10 million in damages. He brings counts of breach of warranties, fraud, violation of the New York consumer protection from deceptive acts and practices law, unjust enrichment, negligence, inadequate warning, and defective design. The case is moving forward in the U.S. District Court for the Eastern District of New York joining other plaintiffs who seek to gain compensation for problems after taking Propecia. Merck accused of downplaying potential Propecia side effects Propecia was approved by the FDA in December of 1997 to treat male pattern hair loss. Containing 1 mg of finasteride, this medication is a lower dose version of the Merck manufactured Proscar. Proscar contains 5 mg of finasteride and is marketed to treat benign prostatic hyperplasia, also referred to as an enlarged prostate. The plaintiff’s attorney claims that Merck spent $60 million in direct-to-consumer advertising to promote Propecia in 1998. In 1999, they spent $125 million. This advertising blitz did not include warnings to consumers of possible Propecia sexual side effects. Merck, until April 2012, stated that fewer than 2 percent of men taking the drug suffered from sexual dysfunction. They also said that these side effects subsided after they ceased using the medication. In addition, they asserted that the side effects stopped in the majority of men who continued taking Propecia. Full article
  4. A man who took the hair loss drug Propecia (finasteride) for only two years, from 2001 to 2003, filed a lawsuit against Merck on November 24, 2012 alleging that he is still suffering from Propecia side effects nearly a decade after he stopped using the drug. The lawsuit has been added to the Propecia MDL in the Eastern District of New York. Inadequate warnings on Propecia label According to the Propecia lawsuit, the plaintiff was prescribed Propecia for his male pattern hair loss when he was 33. Neither he nor his doctor were aware of any significant risks of Propecia, because the warnings on the drug’s label were inadequate, the lawsuit alleges. The original Propecia label assured men that side effects were rare and disappeared once the drug was discontinued. But the plaintiff in this case states that he took Propecia for only two years, from 2001 to 2003, yet suffered erectile dysfunction and cognitive impairment which continue to plague him today, nearly a decade after he stopped using the drug. He adds that he did not have either of these symptoms before he started taking Propecia. Lawsuit accuses Merck of fraud In addition to bringing claims of failure to warn, the plaintiff also accuses Merck of fraud, alleging that the pharmaceutical company willfully concealed evidence of Propecia side effects, specifically results of clinical studies that found a link between Propecia and sexual dysfunction. Despite being aware of these findings, the company continued to aggressively market Propecia as a safe and effective treatment for hair loss, “willfully, wantonly, uniformly, deliberately and recklessly” misrepresenting the safety of the product and concealing the fact that the drug was not adequately tested before being put on the market as a treatment for male pattern baldness, the lawsuit charges. Full article
  5. Despite its "Be well" tagline, Merck & Co. appears to be promoting just the opposite—at least among its Propecia patients. For the second consecutive quarter, the number of individuals who have filed lawsuits against the pharma giant alleging "that they have experienced persistent sexual side effects following cessation of treatment" with the hair-loss medication (or with Proscar, the same drug, finasteride, to treat enlarged prostate) grew at a double-digit rate. According to the company's quarterly report for the period ended Sept. 30, 2012, "approximately 265" product-liability lawsuits "involving a total of approximately 415 plaintiffs...have been filed against Merck." That's a 32.5% rise in the number of lawsuits and a 27.5% rise in plaintiffs over the previous quarter, ended June 31, 2012. Propecia profits, meanwhile, seem to be suffering in tandem. For the quarter ended Sept. 30, 2012, sales of the controversial drug tumbled about 7%, to $104 million, as compared to $112 million for the same period in 2011 A growing epidemic, post-finasteride syndrome (PFS) is characterized by sexual, neurological, hormonal and psychological side effects, including loss of libido, erectile dysfunction, Peyronie's disease, penile shrinkage, gynecomastia, muscle atrophy, cognitive impairment, severely dry skin, and depression. Merck has not responded to repeated requests by The Examiner for comment on Propecia's role in causing PFS in men who have quit the drug. Nor has the company, to The Examiner's knowledge, done anything to help its thousands of customers whose physical and mental health have been devastated by the drug. But the medical and scientific communities have started down the road to clinical explorations of PFS, in hopes of developing a cure. In August, Johns Hopkins University-educated physician John Santmann launched the Post-Finasteride Syndrome Foundation to "fund research on the characterization, underlying biologic mechanisms and treatments of PFS," while helping to increase public awareness of the condition. Full hair loss article
  6. Despite Justin Bieber's recent plea for Prince William to pop Propecia, the perilous hair-loss drug is losing market share at a double-digit pace—while gaining furious customers at a triple-digit clip. According to Merck's quarterly report (SEC Form 10-Q) for the period ended June 30, 2012, Propecia sales totaled $100 million, compared to $112 million for the same period in 2011. That makes for a decline of about 10.5 percent. Meanwhile, the number of plaintiffs who have filed lawsuits against the pharmaceutical giant, alleging "that they have experienced persistent sexual side effects following cessation of treatment with Propecia and/or Proscar [the same drug, finasteride, in a higher dose, to treat enlarged prostate]" has risen significantly. For the quarter ended March 31, 2012, Merck reported "approximately 80 lawsuits involving a total of approximately 175 plaintiffs." And for the quarter ended June 31, 2012, the total number of lawsuits escalated to 200, while total plaintiffs jumped to 325. That's a 150-percent rise in the number of lawsuits, and an 86-percent rise in plaintiffs. This downturn in Propecia sales and upturn in lawsuits comes in the wake of two new studies by Dr. Michael Irwig of George Washington University on the controversial medication's long-terms dangers. The first study, published July 12 in The Journal of Sexual Medicine, reported that 96 percent of the 54 young, previously healthy Propecia patients examined by Dr. Irwig suffered sexual dysfunction for more than a year after quitting the drug. The second study, published last week in The Journal of Clinical Psychiatry, showed that nearly 44 percent of the 61 young, previously healthy Propecia patients reported suicidal thoughts, while 36 percent had severe symptoms of depression. “This study has very important messages when you’re looking at something like suicide and suicidal ideations,” Dr. Irwig, told FoxNews.com. "How many deaths from a medication do you really need to be considered important enough and to change [warning] labels?” Complete hair loss article
  7. This baldness cure was a bust. For nine months, William McKee took the generic version of Propecia, the pills that promise to halt hair loss. But the drug had radical side effects: Instead of becoming a better-looking man, he started becoming a woman, he claims. “My rock-hard chest from the gym began to soften . . . reaching the point where I had noticeable ‘breasts’ even under my clothing,” he says. Among other changes, the 38-year-old software engineer claims, “my shoulders were literally falling into a more feminine position, and my hips were loosening and becoming wider, as on a woman’s body.”’ McKee, who says he wasn’t inclined to cross-dress before, began feeling like a woman. He is now only attracted to men. After overcoming depression and separating from his wife of 10 years, McKee goes by “Mandi.” He wears a blond wig, makeup and tight dresses. He plans to get a breast-enhancement job this year, and may undergo sex-change surgery. “It felt like the ‘me’ that I’ve always known was not there any more,” he told The Post. Propecia inhibits the conversion of testosterone, resulting in increased estrogen. Millions have used it since the 1990s, but it has been linked to sexual problems such as impotence, loss of libido and “genital shrinkage” as well as cognitive impairment, or “brain fog,” which McKee believes he also suffered. Lawsuits filed in 27 states by men who say the wonder drug screwed up their sexuality have been centralized in Brooklyn federal court. Complete hair loss article
  8. Prescribing labels for Merck & Co's drugs for baldness and enlarged prostate will add reports of sexual side effects that continued after use of the medicines was stopped, U.S. health regulators said. Labels will be revised for Proscar, which treats symptoms of enlarged prostate, and hair-loss treatment Propecia, the Food and Drug Administration said. The active ingredient in both drugs is finasteride. The Propecia label will now include notification of problems with libido, ejaculation and orgasms that continued after use of the drug was ended. Proscar's label will include notification of decreased libido. The labels of both drugs will also include a description of reports of male infertility and poor semen quality that normalized or improved after use of the drugs was stopped. In announcing the label changes, FDA cited events reported to the agency. "The cases suggest a broader range of adverse effects than previously reported in patients taking these drugs," FDA said in a notification posted on its website. But it also said no clear causal links between finasteride and sexual adverse events had been established. FDA said sexual side effects were included in the labels of both drugs when they were approved in the 1990s. But in subsequent clinical trials, the side effects were resolved in patients who stopped using the drugs as well as in most patients who continued therapy, the agency said. Complete hair loss article
  9. Just to let you guys know that Feller Medical has launch its NEW website. http://fellermedical.com Best Spex
  10. Merck & Co. has agreed that all Propecia lawsuits filed in federal district courts throughout the United States by men who experienced sexual problems after using their hair-loss drug should be consolidated before one judge for pretrial proceedings. Merck Prefers New Jersey Merck has suggested that the U.S. Judicial Panel on Multidistrict Litigation should transfer all cases to the U.S. District Court for the District of New Jersey, where 41 of the 53 lawsuits over Propecia have already been filed. Some plaintiffs proposed that the Propecia MDL be centralized in the U.S. District Court for the Eastern District of New York, or, in the alternative, in the U.S. District Court for the Western District of Washington. Merck’s attorneys claim that moving the cases to the Eastern District of New York, or the Western District of Washington, would be inefficient because the courts lack familiarity with issues already addressed in a number of the cases. Complete Propecia article
  11. A man who took the male pattern baldness drug Propecia for four years claims it gave him "severe sexual dysfunction and cognitive impairment." Jason McCord sued Merck & Co. in Federal Court. Merck has been sued at least 15 times in the past two years for similar claims, according to the Courthouse News database. McCord says he was 36 when he was prescribed Propecia, in 2006, and he took it for four years. He says the trade-off wasn't worth it. "Male pattern hair loss affects 30 percent of men by the age of 30 years and 50 percent of men by the age of 50 years. Men who suffer from hair loss may be perceived as older and less physically and socially attractive," according to the complaint. "Male pattern hair loss is a common condition thought to be caused by a combination of genetic factors and a hormone called dihydrotestosterone ('DHT'). "DHT is a substance in the body that can shrink hair follicles until a person no longer has hair on top of his head. "Finasteride is a 5-alpha reductase inhibitor that decreases the conversion of testosterone to DHT, therefore, preventing hair loss. "Propecia, or finasteride, may produce undesirable side effects to patients who use the prescription drug, including but not limited to, sexual dysfunction and cognitive impairment. "The rates of the sexual dysfunction as a result of finasteride are reported to be as high as 39 percent in published clinical studies. In addition, it has been reported in 2003 that only 50 percent of patients experience resolution of their sexual function adverse events after discontinuation of finasteride." Complete hair loss article
  12. The International Society of Hair Restoration Surgery (ISHRS) -- the world's leading medical authority on hair loss and hair restoration -- cautions that recent anecdotal reports of persistent sexual dysfunction by some men who have used finasteride 1mg (Propecia) to treat hair loss should not define the safety and effectiveness of this drug. Propecia is the only oral medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of hair loss in men. From a scientific standpoint, the ISHRS reports that there are no evidence-based data substantiating the link between finasteride and persistent sexual side effects after discontinued use of the drug in numerous, double blinded, placebo controlled studies conducted evaluating the use of Propecia 1mg for hair loss. "The health and well being of our patients is the utmost concern of the 900 physician members of the ISHRS -- whether prescribing medications like Propecia or performing hair restoration surgery," said ISHRS President Dr. Jennifer Martinick. "ISHRS members devote an average of 72% of their practices to medically and surgically treating hair loss, and collectively they have treated millions of men around the world suffering from hair loss with finasteride 1mg with virtually no side effects." Since receiving FDA approval in December of 1997, 20.5 million and 6.7 million patient-years of exposure using Proscar (finasteride 5mg) and Propecia (finasteride 1mg) respectively are recorded with a low adverse event profile. The ISHRS believes that these are the most current and reliable data available until further studies are conducted. Full article
  13. Before now, there has been no study of finasteride use exceeding 1 year in Japanese men with androgenetic alopecia (AGA) except the study subsequently conducted from the development phase. Since the launch of finasteride, no study in a larger population had been reported. Ethnic variation of the onset age, progressive nature and degree of hair loss of androgenetic alopecia are known. The therapeutic effect of oral finasteride (Propecia) was examined on androgenetic alopecia of Japanese men. The efficacy and safety of finasteride (1 mg tablet) was evaluated in Japanese men with AGA in the long term. The study enrolled 3177 men given finasteride 1 mg/day from January 2006 to June 2009 at our clinic. Efficacy was evaluated in 2561 men by the modified global photographic assessment; the photographs were assessed using the standardized 7-point rating scale. Safety data were assessed by interviews and laboratory tests in all men enrolled in the study. The overall effect of hair growth was seen in 2230 of 2561 men (87.1%), in whom hair greatly (11.1%), moderately (36.5%) and slightly (39.5%) increased. The response rate improved with increasing duration of treatment. Full Propecia article
  14. An unidentified man in Colorado has filed suit against the maker of Propecia, claiming the male baldness drug caused him to suffer erectile dysfunction and other sexual problems. The claim, brought in U.S. District Court for the District of Colorado, is just the latest Propecia lawsuit filed against Merck & Co. by men who say that the drug caused sexual issues. Propecia (known generically as finasteride 1 mg) is part of a class of drugs called 5-alpha reductase inhibitors, or 5-ARIs. Other drugs in this class including Merck’s Proscar (finasteride 5 mg), and GlaxoSmithKline’s Avodart (dutasteride) and Jalyn (dutasteride and tamsulosin) are manufactured by GlaxoSmithKline. While Propecia is used to treat male pattern baldness, other 5 ARIs are used to treat enlarged prostate. According to the U.S. Food & Drug Administration (FDA), almost 5 million men were prescribed one of these medications between 2002 and 2009. Propecia and these other drugs work by preventing the conversion of androgen testosterone to DHT, a hormone critical to male sexual performance. Merck’s label for Propecia warns that side effects may include sexual dysfunction but says the side effects “resolve after discontinued use of the drug.” While the Propecia label in Europe was updated in 2008 to warn of “persistent” sexual side effects, no such update has occurred in the U.S. In March, a group of researchers at Boston University published a study finding that in a small number of cases, erectile dysfunction linked to 5-ARIs may continue after the drugs have been discontinued. The study, which involved a review of available medical literature, found that 8 percent of men taking 5-ARIs reported erectile dysfunction and 4.2 percent reported reduced libido. In the placebo group, only 4 percent reported erectile dysfunction, while only 1.8 percent reported reduced libido. Other men taking the drugs reported reduced ejaculation and semen volume and depression. In some cases, men experienced problems after taking the drugs. Complete Propecia article
  15. As reported by the Guardian, the first winner of Pop Idol contest Will Young candidly admits to taking prescription-based hair loss medication Propecia finasteride after he started balding. Known for his outspoken nature yet pleasant demeanor, Young said to the Leading British daily that male pattern baldness was slowly but surely affecting his confidence. “It’s such an awful thing for men”, the Guardian quoted him as saying. Saying that hair loss made him conscious about his appearance, the pop star said he detested the idea of living with it and chose the clinical route to reverse the situation. It may be noted that Propecia can not only prevent hair loss, but can in fact initiate hair regrowth when used consistently over a period of time under medical supervision. When asked if he would follow Wayne Rooney in getting a hair transplant done to prevent further balding in future, Will Young did not hesitate for a moment to say yes. He also had a go at someone found spreading rumours that he had already had a hair transplant, the Guardian discloses, adding that the young singer-songwriter said he never had anything to conceal about his hair loss. Full Propecia article
  16. Hi guys and girls, Over the last year i have been working incredibly hard behind the scenes on my new comprehensive Hair loss project: >>> MaximumHairMinimumLoss.com <<< It is a collective insight of ALL my 10 years personal experiences with hair loss and hair restoration and my insider knowledge of this brutal hair loss industry. It also includes the experiences i have gained from the countless hair loss suffers i have met, helped and interacted with over the last 10 years.The project is ultimately my lifes work and contains ALL my knowledge, tricks, tips and insights. It is something i know for a FACT is going to very much help, arm and empower all hair loss sufferers. It has already been reviewed and given huge recognition by industry insiders and also leading Hair Restoration Drs. This is something I am incredibly proud of and you can see the testimonies on the site. I highly recommend looking over the website and reviewing the feedback and testimonies as I am confident 'MaximumMinimumLoss' can also most certainly help you on your own hair loss journey. Kind Regards Spex MaximumHairminimumLoss.com
×
×
  • Create New...